Compare KRT & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | ALT |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.5M | 501.9M |
| IPO Year | 2021 | N/A |
| Metric | KRT | ALT |
|---|---|---|
| Price | $22.02 | $5.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $29.67 | $16.33 |
| AVG Volume (30 Days) | 155.6K | ★ 3.3M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 8.17% | N/A |
| EPS Growth | ★ 6.32 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $453,775,000.00 | $20,000.00 |
| Revenue This Year | $10.75 | N/A |
| Revenue Next Year | $6.69 | N/A |
| P/E Ratio | $14.69 | ★ N/A |
| Revenue Growth | ★ 8.93 | N/A |
| 52 Week Low | $20.61 | $2.90 |
| 52 Week High | $33.89 | $10.88 |
| Indicator | KRT | ALT |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 74.79 |
| Support Level | $20.61 | $4.40 |
| Resistance Level | $21.78 | $4.75 |
| Average True Range (ATR) | 0.60 | 0.29 |
| MACD | 0.06 | 0.10 |
| Stochastic Oscillator | 68.85 | 92.19 |
Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. The company operates and evaluates its business as a single reportable segment which encompasses the manufacturing and distribution of a diverse range of single-use food and beverage service products made from materials such as plastic, paper, biopolymer-based, and other compostable forms. The company offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.